You are here
Innovax®-ND-IBD suspension and solvent for suspension for injection for chickens
Innovax-ND-IBD is a live viral vaccine developed to induce active immunity against Newcastle disease, infectious bursal disease (Gumboro disease) and Marek’s disease in chickens.
Presentation
Off-red to red suspension and clear, red solvent for suspension for injection
Active ingredients
Each dose of reconstituted vaccine (0.2 ml) contains:
Cell-associated live recombinant turkey herpesvirus (strain HVP360), expressing the fusion protein of Newcastle disease virus and the VP2 protein of infectious bursal disease virus: 103.3 – 104.6 PFU1.
1 PFU – plaque forming units.
Target species
Chickens and embryonated chicken eggs.
Indications for use
For active immunisation of one-day-old chicks or 18–19 day-old embryonated chicken eggs:
- to reduce mortality and clinical signs caused by Newcastle disease (ND) virus
- to prevent mortality and to reduce clinical signs and lesions caused by infectious bursal disease (IBD) virus
- to reduce mortality, clinical signs and lesions caused by Marek’s disease (MD) virus
Onset of immunity: ND: 4 weeks, IBD: 3 weeks, MD: 9 days
Duration of immunity: ND: 60 weeks, IBD: 60 weeks, MD: entire risk period
Withdrawal periods
Poultry - meat 0 days
Packaging
Cell concentrate:
- One Type I glass ampoule of 2 ml containing 2,000 or 4,000 doses. Ampoules are stored on a cane and attached to the cane is a coloured clip displaying the dose (2,000 doses: salmon-pink coloured clip, and 4,000 doses: yellow coloured clip).
Solvent:
- One 400 ml polyethylene or multilayer plastic bag
- One 800 ml polyethylene or multilayer plastic bag
Store and transport frozen in liquid nitrogen (below -140 °C). Store liquid nitrogen container securely in upright position in a clean, dry and well-ventilated room separated from the hatching/chicken room in the hatchery.
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Date of preparation: March 2023